TXN's FCF Improvement Supports Returns, But Valuation Leaves Little Room for Error

What happened

Texas Instruments' free cash flow is improving as revenue growth returns and capital spending moderates after a six-year build cycle, strengthening its ability to reward shareholders through dividends and buybacks. However, the stock at $269.5 already prices in a broad analog recovery with a P/E of 45.6 and EV/EBITDA of 31, leaving limited multiple-based protection. The key question is whether the Q1'26 industrial rebound (+30% YoY) is a durable recovery or a restock burst, as management itself acknowledged a prior 'head fake.' While data center growth (~90% YoY) provides an incremental tailwind, it remains a small portion of revenue at ~9%, and tariff exposure (~50% of revenue shipped into China) adds downside risk. Until Q2'26 results confirm sustained demand and inventory days trend below 200, the risk/reward is unattractive for new entries.

Implication

For existing holders, monitor Q2'26 revenue between $5.0B-$5.4B and inventory days below 200; a miss would signal a false start and warrant reduction. The FCF improvement is real but already priced in; the bull case requires sustained industrial breadth and data center growth without trade disruption.

Thesis delta

The narrative is shifting from 'analog slump' to 'recovery' with FCF as a new catalyst, but the master report's cautious stance remains valid because the recovery is unconfirmed and valuation is stretched. The delta is that market optimism is increasing, but fundamental confirmation is still pending.